Copy Link to Highlight
...
RegLinks
Faron Pharmaceuticals Oy
Faron hits key milestone with BEXMAB Phase 2 completion, advances to registrational trial with FDA alignment
Nov. 3, 2025, 7 a.m.
Link to Selection